Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Bauer

Showing results (271-280 of 408) with videos related to

Pageof 41
Sort By:
Journal of Medicinal Chemistry|June 19, 2013
Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound designAndré Richters, Julia Ketzer, Matthäus Getlik, et al.
Epilepsy & Behavior : E&B|November 13, 2020
SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experienceLaurent M Willems, Yunus Balcik, Anna H Noda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
<sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational TrialLukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Seizure|May 4, 2013
Levetiracetam but not valproate inhibits function of CD8+ T lymphocytesGang Li, Mareike Nowak, Sebastian Bauer, et al.
Disease Models & Mechanisms|October 30, 2012
Phenotypic overlap in the contribution of individual genes to CNV pathogenicity revealed by cross-species computational analysis of single-gene mutations in humans, mice and zebrafishSandra C Doelken, Sebastian Köhler, Christopher J Mungall, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 25, 2025
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation lossHannah Zillikens, Corinna Scheib, Vicky Peller, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.
Orphanet Journal of Rare Diseases|April 30, 2021
The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter studyNicholas M Bernthal, Geert Spierenburg, John H Healey, et al.
Cell Death and Differentiation|September 13, 2023
Identification of novel pathogenic roles of BLZF1/ATF6 in tumorigenesis of gastrointestinal stromal tumor showing Golgi-localized mutant KITYujin Kwon, Jiyoon Kim, Su-Yeon Cho, et al.
Epilepsy & Behavior : E&B|November 27, 2020
Advantages of methohexital over amobarbital in determining hemispheric language and memory lateralization in the Wada test - A retrospective studyNadine Conradi, Friederike Rosenberg, Louise Biermann, et al.
Pageof 41

Showing results (271-280 of 408) with videos related to

Sort By:
Pageof 41
Journal of Medicinal Chemistry|June 19, 2013
Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound designAndré Richters, Julia Ketzer, Matthäus Getlik, et al.
Epilepsy & Behavior : E&B|November 13, 2020
SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experienceLaurent M Willems, Yunus Balcik, Anna H Noda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
<sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational TrialLukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Seizure|May 4, 2013
Levetiracetam but not valproate inhibits function of CD8+ T lymphocytesGang Li, Mareike Nowak, Sebastian Bauer, et al.
Disease Models & Mechanisms|October 30, 2012
Phenotypic overlap in the contribution of individual genes to CNV pathogenicity revealed by cross-species computational analysis of single-gene mutations in humans, mice and zebrafishSandra C Doelken, Sebastian Köhler, Christopher J Mungall, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 25, 2025
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation lossHannah Zillikens, Corinna Scheib, Vicky Peller, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.
Orphanet Journal of Rare Diseases|April 30, 2021
The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter studyNicholas M Bernthal, Geert Spierenburg, John H Healey, et al.
Cell Death and Differentiation|September 13, 2023
Identification of novel pathogenic roles of BLZF1/ATF6 in tumorigenesis of gastrointestinal stromal tumor showing Golgi-localized mutant KITYujin Kwon, Jiyoon Kim, Su-Yeon Cho, et al.
Epilepsy & Behavior : E&B|November 27, 2020
Advantages of methohexital over amobarbital in determining hemispheric language and memory lateralization in the Wada test - A retrospective studyNadine Conradi, Friederike Rosenberg, Louise Biermann, et al.
Pageof 41